Enzymuria determination in children treated with aminoglycosides drugs

Human and Experimental Toxicology

Volumn 27, Issue 12, 2008, Pages 879-882

  Mohammadi Karakani, A ^a,b   Asgharzadeh Haghighi, S ^a   Ghazi Khansari, M ^a,b   Seyed Ebrahimi, A ^a   Ghasemi, A ^a   Jabari, E ^a  

^a Social Security Organization   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aminoglycosides antibiotics; Children; Serum creatinine; Urinary enzymes

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; AMIKACIN; CREATININE; GENTAMICIN; LACTATE DEHYDROGENASE; N ACETYL BETA GLUCOSAMINIDASE; UREA;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; ENZYMURIA; FEMALE; GASTROENTERITIS; HUMAN; INFANT; INFECTION; MALE; NEWBORN; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; UREA BLOOD LEVEL; URINE LEVEL;

ACETYLGLUCOSAMINIDASE; ALBUMINURIA; ALKALINE PHOSPHATASE; AMIKACIN; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; CLINICAL ENZYME TESTS; CREATININE; FEMALE; GENTAMICINS; HUMANS; INFANT; KIDNEY DISEASES; L-LACTATE DEHYDROGENASE; MALE; PREDICTIVE VALUE OF TESTS; TIME FACTORS; UP-REGULATION; UREA;

EID: 62249092363     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327108100417     Document Type: Article

References (24)

1. Hammett-Stabler CA. Johns T.. Laboratory guidelines for monitoring of antimicrobial drugs. National Academy of Clinical Biochemistry. Clin Chem 1998 ; 44: 1129-1140.
2. Mendoza SA.. Nephrotoxic drugs. Pediatr Nephrol 1988 ; 2: 466-476.
3. Beauchamp D. Labrecque G.. Aminoglycoside nephrotoxicity: do time and frequency of administration matter. Curr Opin Crit Care 2001 ; 7: 401-408.
4. Mingeot-Leclercq MP. Tulkens PM.. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 1999 ; 43: 1003-1012.
5. Nagai J. Takano M.. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet 2004 ; 19: 159-170.
6. Vaidya VS. Bonventre JV.. Mechanistic biomarkers for cytotoxic acute kidney injury. Expert Opin Drug Metab Toxicol 2006 ; 2: 697-713.
7. Hewitt SM. Dear J. Star RA.. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004 ; 15: 1677-1689.
8. Skalova S. Chladek J.. Urinary N-acetyl-beta-D-glucosaminidase activity in healthy children. Nephrology (Carlton) 2004 ; 9: 19-21.
9. Tassi C. Abbritti G. Mancuso F. Morucci P. Feligioni L. Muzi G.. Activity and isoenzyme profile of N-acetyl-beta-D-glucosaminidase in urine from workers exposed to cadmium. Clin Chim Acta 2000 ; 299: 55-64.
10. Skalova S.. The diagnostic role of urinary N-acetyl-beta-D- glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Medica (Hradec Kralove) 2005 ; 48: 75-80.
11. Mohammadi-Karakani A. Asgharzadeh-Haghighi S. Ghazi-Khansari M. Hosseini R.. Determination of urinary enzymes as marker of early renal damage in diabetic patients. J Clin Lab Anal 2007 ; 21: 413-417.
12. Hosseini R. Dehpour AR. Rad MH. Rankohi KE.. An improved method for evaluation of nephrotoxicity by assay of urinary N-Acetyl-á-D- Glucosaminidase (NAG) activity. Toxicol Methods 1997 ; 7: 153-176.
13. Periti P.. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy. J Chemother 1995 ; 7: 311-337.
14. Prins JM. Weverling GJ. van Ketel RJ. Speelman P.. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients. Clin Pharmacol Ther 1997 ; 62: 106-111.
15. Beauchamp D. Laurent G. Maldague P. Abid S. Kishore BK. Tulkens PM.. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. J Pharmacol Exp Ther 1990 ; 255: 858-866.
16. Gibey R. Dupond JL. Alber D.. Leconte des Floris, R, Henry, JC. Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin. Clin Chim Acta 1981 ; 116: 25-34.
17. Whiting PH. Brown PA.. The relationship between enzymuria and kidney enzyme activities in experimental gentamicin nephrotoxicity. Ren Fail 1996 ; 18: 899-909.
18. Assadamongkol K. Tapaneya-Olarn W. Chatasingh S.. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in aminoglycoside nephrotoxicity. J Med Assoc Thai 1989 ; 1: 42-46.
19. Wiland P. Szechcinski J.. Proximal tubule damage in patients treated with gentamicin or amikacin. Pol J Pharmacol 2003 ; 55: 631-637.
20. Marchewka Z. Dlugosz A.. Enzymes in urine as markers of nephrotoxicity of cytostatic agents and aminoglycoside antibiotics. Int Urol Nephrol 1998 ; 30: 339-348.
21. McCracken GH.. Aminoglycoside toxicity in infants and children. Am J Med 1986 ; 80: 172-178.
22. Heimann G.. Renal toxicity of aminoglycosides in the neonatal period. Pediatr Pharmacol (New York) 1983 ; 3: 251-257.
23. Baliga R. Ueda N. Walker PD. Shah SV.. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 1999 ; 31: 971-997.
24. Vaidya VS. Ramirez V. Ichimura T. Bobadilla NA. Bonventre JV.. Kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006 ; 290: F517-F529.